Mobile Cued Adherence Therapy (mCAT) for Blood Pressure Medication

Launched by CHAD STECHER@ASU.EDU · Mar 13, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new approach called Mobile Cued Adherence Therapy (mCAT) to help people with high blood pressure (hypertension) remember to take their medication regularly. The researchers want to find out if giving daily rewards for taking blood pressure pills can help people stick to their medication schedule, keep their blood pressure under control, and reduce healthcare costs. They will also look at whether adding a simple action plan, like saying, "After I drink my morning coffee, I will take my medication," makes this method more effective. Participants will be divided into three groups: one will receive daily rewards only, another will get rewards plus action planning, and the third group won’t receive any rewards or planning.

To be eligible for this study, participants must be at least 18 years old, diagnosed with high blood pressure, able to read and understand English, have a smartphone, and have been prescribed blood pressure medication for at least a year. They should also have struggled to take their medication consistently in the past year. Participants can expect to complete five online surveys over two years, provide blood pressure readings after each survey, and share photos of their medication for four months if they are in the intervention groups. Additionally, some participants will be invited for a brief interview to discuss their experiences with the program. This study hopes to find effective ways to help people manage their hypertension better.

Gender

ALL

Eligibility criteria

• Eligibility Criteria:
• • Aged 18 years or older
• • Currently diagnosed with hypertension (either stage I or stage II hypertension)
• • Able to read/write/understand English
• • Have daily access to a smartphone
• • Engaged in hypertension care: Already been prescribed hypertension medication for a minimum of 12 months at the time of study enrollment
• • Demonstrated AH medication nonadherence by having over 73 days without documented AH medication prescription coverage (observable in Arizona Health Care Cost Containment System (AHCCCS) prescription drugs claims) in the past 12 months (i.e. \<80% mean adherence)